Evidence map›Paper›PMID 39288891›Full record

ArticleJournal of controlled release : official journal of the Controlled Release Society2024

Wearable nitric oxide-releasing antibacterial insert for preventing device-associated infections.

Manjyot Kaur Chug, Aasma Sapkota, Mark Garren, Elizabeth J Brisbois

Abstract read
In one paragraph

Article in Journal of controlled release : official journal of the Controlled Release Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Therapeutic Gases in Biomedicine: Updates on Nitric Oxide and Beyond.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Manjyot Kaur ChugSchool of Chemical, Materials & Biomedical Engineering, University of Georgia, Athens, GA, USA.
Aasma SapkotaSchool of Chemical, Materials & Biomedical Engineering, University of Georgia, Athens, GA, USA.
Mark GarrenSchool of Chemical, Materials & Biomedical Engineering, University of Georgia, Athens, GA, USA.
Elizabeth J BrisboisSchool of Chemical, Materials & Biomedical Engineering, University of Georgia, Athens, GA, USA. Electronic address: ejbrisbois@uga.edu.

Funding

Prevention of catheter related infections via photoactive nitric oxide delivery deviceR01HL170574 · NHLBI · UNIVERSITY OF GEORGIA · PI Elizabeth Joy Brisbois · 2023 to 2026
$1.8M
NHLBI NIH HHS R01 HL170574
6 · The paper itself

Abstract

Medical device-associated infections are a pervasive global healthcare concern, often leading to severe complications. Bacterial biofilms that form on indwelling medical devices, such as catheters, are significant contributors to infections like bloodstream and urinary tract infections. This study addresses the challenge of biofilms on medical devices by introducing a portable antimicrobial catheter insert (PACI) designed to be efficient, biocompatible, and anti-infective. The PACI utilizes nitric oxide (NO), known for its potent antimicrobial properties, to deter bacterial adhesion and biofilm formation. To achieve this, a photoinitiated NO donor, S-nitroso-N-acetylpenicillamine (SNAP), is covalently linked to a polydimethylsiloxane (PDMS) polymer. This design allows for higher NO loading for long-term impact and prevents premature donor leaching, a common challenge with SNAP-blended polymers. The SNAP-PDMS material was applied to a side-glowing fiber optic and connected to a wearable light module emitting 450 nm light, creating a functional antimicrobial insert. Activation of the fiber optic, accomplished with a one-click mechanism, enables real-time NO release, maintaining controlled NO levels for a minimum of 24  hours. The therapeutic levels of NO released via photocatalysis from the PACI demonstrated remarkable efficacy, with >90 % reduction in bacterial viability against S. aureus, S. epidermidis, and P. mirabilis without any cytotoxic impact on mammalian cells. This study underscores the potential of the NO-releasing insert in clinical settings, providing a portable and adaptable solution for preventing catheter-associated infections.

Indexed as

Anti-Bacterial AgentsBiofilmsDimethylpolysiloxanesNitric OxideNitric Oxide DonorsS-Nitroso-N-AcetylpenicillamineWearable Electronic DevicesAnimalsCatheter-Related InfectionsHumansStaphylococcus aureusStaphylococcus epidermidisAnti-Bacterial AgentsbaysilonDimethylpolysiloxanesNitric OxideNitric Oxide DonorsS-Nitroso-N-AcetylpenicillamineAntibacterial insertCatheter disinfectionNitric oxidePortableWireless

Identifiers

PMID39288891
PMCPMC11748947

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.